Literature DB >> 9397135

Excretion of epidermal growth factor in human adult polycystic kidney disease.

T Weinstein1, D Hwang, A Lev-Ran, Y Ori, A Korzets, J Levi.   

Abstract

In chronic renal failure, epidermal growth factor (EGF) excretion is decreased. In this study, asymptomatic adult polycystic kidney disease (APKD) patients with a relatively preserved glomerular filtration rate were examined. Excretion of EGF was studied in 6 patients with APKD (median age 42 years; serum creatinine [median] 95 [range-80-133] mumol/l) and compared with that of 28 healthy controls. EGF was determined in a spot morning urine by using a specific radioimmunoassay, and expressed in relation to creatinine excretion. Excretion of EGF in APKD was (median) 157 (range-13-359) and in the controls (median) 546 (range-238-1199) pmol/mmol creatinine (p < 0.001). Low excretion of EGF in APKD patients with preserved kidney function suggests a distal abnormality at an early stage of the disease, prior to the development of renal failure.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9397135

Source DB:  PubMed          Journal:  Isr J Med Sci        ISSN: 0021-2180


  4 in total

1.  The biomarker enriched proteome of autosomal dominant polycystic kidney disease cyst fluid.

Authors:  Stephen B Mason; Xianyin Lai; Robert L Bacallao; Bonnie L Blazer-Yost; Vincent H Gattone; Kevin C Wang; Frank A Witzmann
Journal:  Proteomics Clin Appl       Date:  2009-06-24       Impact factor: 3.494

Review 2.  Diagnosis, pathogenesis, and treatment prospects in cystic kidney disease.

Authors:  Carsten Bergmann; Valeska Frank; Fabian Küpper; Dirk Kamitz; Jens Hanten; Peter Berges; Silke Mager; Markus Moser; Jutta Kirfel; Reinhard Büttner; Jan Senderek; Klaus Zerres
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

3.  Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker.

Authors:  Wenjun Ju; Viji Nair; Shahaan Smith; Li Zhu; Kerby Shedden; Peter X K Song; Laura H Mariani; Felix H Eichinger; Celine C Berthier; Ann Randolph; Jennifer Yi-Chun Lai; Yan Zhou; Jennifer J Hawkins; Markus Bitzer; Matthew G Sampson; Martina Thier; Corinne Solier; Gonzalo C Duran-Pacheco; Guillemette Duchateau-Nguyen; Laurent Essioux; Brigitte Schott; Ivan Formentini; Maria C Magnone; Maria Bobadilla; Clemens D Cohen; Serena M Bagnasco; Laura Barisoni; Jicheng Lv; Hong Zhang; Hai-Yan Wang; Frank C Brosius; Crystal A Gadegbeku; Matthias Kretzler
Journal:  Sci Transl Med       Date:  2015-12-02       Impact factor: 17.956

4.  Urinary prostaglandin E2 is a biomarker of early adaptive hyperfiltration in solitary functioning kidney.

Authors:  Tarak Srivastava; Wenjun Ju; Ginger L Milne; Mohamed H Rezaiekhaligh; Vincent S Staggs; Uri S Alon; Ram Sharma; Jianping Zhou; Ashraf El-Meanawy; Ellen T McCarthy; Virginia J Savin; Mukut Sharma
Journal:  Prostaglandins Other Lipid Mediat       Date:  2019-12-12       Impact factor: 3.813

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.